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ABSTRACT
Background and Objectives: Surgical treatment of
esophageal cancer is associated with a high rate of mor-
bidity, even in specialized centers. Minimally invasive
esophageal resection has become increasingly feasible
and is gaining popularity in some high-volume institu-
tions. This study assesses the short-term outcomes of lapa-
roscopic transhiatal esophagectomy performed by a single
surgeon at a single low-volume institution over a 20-
month period.
Methods: Over the study period, 16 patients underwent
laparoscopic transhiatal esophagectomy. All patients were
men with an average age of 70 years (range, 50 to 81).
Results: Two patients required intraoperative conversion
to alternative surgical techniques, 1 to an Ivor-Lewis
esophagectomy and 1 to an open transhiatal approach.
Average operative time was 198 minutes (range, 147 to
303). Mean hospital stay was 16.7 days (range, 9 to 30).
The average number of resected lymph nodes was 11.7,
and 2 patients had benign pathology. No deaths occurred
in the 30-day postoperative period.
Conclusion: Laparoscopic transhiatal esophagectomy is
an advanced laparoscopic procedure that can be per-
formed with equivalent morbidity and mortality by a low-
volume surgeon in a low-volume center with results com-
parable to those of high-volume centers. While several
authors have demonstrated a correlation between lower
mortality rates and high-volume esophagectomy hospi-
tals, our results support surgeon experience as more im-
portant than the absolute number of procedures per-
formed each year.
Key Words: Laparoscopic transhiatal esophagectomy,
Lymph nodes, Intraoperative conversion.
INTRODUCTION
Ever since Franz Torek successfully performed the first
esophagectomy in 1913, esophagectomy has been a
daunting task associated with substantial morbidity and
mortality.1 Surgeons have long debated the optimal tech-
nique as well as physical location (volume-based reports)
for such an operation to be performed safely.2–6 With
advancing technology, the role of a minimally invasive
approach to this complex procedure has continued to
evolve.7–9 Based on the principal of achieving an equally
successful oncologic resection and pathologic staging,
minimally invasive esophagectomies (MIEs) have been
believed to be associated with at least an equal and some-
times a lower morbidity rate than the more conventional
open approaches.10–13 In 2007, Gemmill and McCulloch14
conducted the largest review of MIEs in the medical liter-
ature. This group concluded that while the operation may
be associated with lower mortality, fewer respiratory com-
plications, less blood loss, and shorter lengths of hospital
stay, more studies would be needed to help shed light on
the full realm of possible morbidities and mortalities re-
lated to the less-invasive approach.
Much of the current literature has focused on the overall
number of esophageal resections performed each year,
leading to the belief that higher volume centers have
better success.3–6 In 2005, Dimick et al6 demonstrated a
trend toward reduction in esophagectomy related mortal-
ity with increased hospital volume. In this study, they
examined in-house mortality rates between low (7
esophagectomies/year) and high volume (7 esophagec-
tomies/year) institutions. The results showed mortality
rates as high as 15.3% for low-volume centers and 7.5% for
high-volume hospitals. Thus, Dimick et al6 concluded that
the greater the number of esophagectomies a hospital
performed each year, the lower their mortality rate. Sim-
ilarly a meta-analysis5 in 2004 focused on hospital volume
and mortality rates from esophagectomy. Low-volume
centers were defined as having performed 2 to 10 esoph-
agectomies per year, and medium- and high-volume cen-
ters performed 11 to 20 and 20 per year, respectively.
The authors concluded that significantly higher rates of
mortality were demonstrated in low-volume hospitals
(median 18% mortality rate) compared to high-volume
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SCIENTIFIC PAPERcenters (median 4.9% mortality rate). As we have reported
previously, this conclusion may not paint the whole pic-
ture or account for the multitude of factors that play a role
in postoperative outcomes.15 In this report, we present
our current retrospective cohort series of MIEs to investi-
gate whether volume status is a predictor for successful
outcomes in a low-volume institution.
MATERIALS AND METHODS
We queried the surgeon’s operative case log to identify
patients who had undergone MIE. Data were queried
using ChartMaxx (MedPlus Inc., Mason, OH) and then
analyzed using Microsoft Excel (Microsoft Corp, Red-
mond, WA). Data were collected for an approximate 20-
month period beginning December 23, 2006 (when the
surgeon first began performing this operation) and ending
September 15, 2008. We chose the time frame to obtain an
inclusive operative experience of a single surgeon in a
community-based, tertiary care teaching hospital. The sur-
geon has not completed any advanced training for this
operation. Patients were selected for this review if they
had undergone a complete MIE or attempted MIE that was
converted to an open procedure during the specified time
period. The surgeon did not perform an esophagectomy
using any technique other than those included in this
study during this time period. Of note, there were no
other esophagectomies performed by other surgeons at
this institution during the study period.
The preoperative workup included esophagogastrodoud-
enotomy (EGD), endoscopic ultrasound (EUS), positron
emission tomography (PET) scanning, and all patients
underwent computed tomographic (CT) scanning. Nutri-
tional parameters were assessed uniformly, and each pa-
tient was required to have a prealbumin 15 before un-
dergoing the operation. This was achieved via Dobbhoff
tube feeding placement in the preoperative setting. If
patients were selected for preoperative neoadjuvant
chemo- and radiation therapy, the surgeon followed these
patients closely to ensure adequate nutritional status was
maintained. Additionally, all patients were evaluated pre-
operatively by a cardiologist and pulmonologist.
Variables queried for included patient age at the time of
operation, race, comorbid conditions including positive
social histories, operative time (skin incision to skin clo-
sure), intra- and postoperative complications, estimated
blood loss, and length of hospital stay. Preoperative eval-
uation, including EGD, EUS, PET scan, or CT, were also
queried, as were perioperative adjuvant treatments with
chemotherapy or radiation.
Surgical Procedure
The abdominal trocars are placed after gaining pneumo-
peritoneum by Veress needle access in the left upper
quadrant (eg, Palmer’s point). The trocars are placed in
the standard location used for esophagogastic surgery,
such as Heller myotomy and fundoplication. Examination
is carried out laparoscopically to look for undetected in-
traperitoneal spread, and laparoscopic ultrasound and bi-
opsy are utilized for any questionable liver lesions. The
dissection is begun at the hiatus freeing the esophagus
and proximal stomach from their attachments. The esoph-
ageal hiatus is then enlarged if needed by dissecting be-
tween the central tendon of the diaphragm and pericar-
dium with a blunt right angle dissector and dividing the
tendon with a white laparoscopic load in the stapling
device.
The stomach is then mobilized starting at the origin of the
left gastroepiploic artery and carried toward the duode-
num, carefully preserving the gastroepiploic arcade. The
short gastrics are then taken down until the greater curve
of the stomach is mobilized to the hiatus. Attachments in
the lesser sac are then divided. The Harmonic scalpel
(Ethicon Endo-Surgery, Inc., Cincinnati, Ohio) is used to
complete all of the sharp dissection. The left gastric artery
is then divided using a grey load in the stapling device.
If further mobilization of the stomach is needed, a Kocher
maneuver is then performed. The viability of the stomach
is assessed, and if it is adequate to allow formation of a
gastric tube with anastomosis in the neck, the esophageal
dissection is begun. A second surgeon dissects out the
cervical esophagus as dissection is carried out from above
and below. The Nathanson retractor (Mediflex, Islandia,
NY) which, up to this point, has been used to hold the left
lateral liver segments anterior and superiorly out of the field
of dissection, is now repositioned to hold open the divided
hiatus. This also allows for wide exposure into the chest. The
esophageal dissection is completed under direct vision to
above the left mainstem bronchus. Care is taken to dissect
all nodes in continuity with the specimen.
Once the esophageal dissection is complete, the stomach
is divided with multiple green loads in the stapling device
from the third or fourth neurovascular bundle on the
lesser curve to the fundus to create a gastric tube. A long
three-quarter inch wide Penrose drain is then sewn to the
gastric tube at the proposed site of esophagogastrostomy.
The specimen is delivered through the neck with gentle
retraction and upward pressure on the Penrose with a
long laparoscopic Babcock grasper.
Laparoscopic Transhiatal Esophagectomy at a Low-Volume Center, Santin BJ et al.
JSLS (2011)15:41–46 42The cervical esophagus is divided, and margins are
checked both grossly and with frozen section. The naso-
gastric tube is measured and inserted into the gastric
pull-up prior to completing the anastomosis. The anasto-
mosis is created using either the double staple technique
described by Orringer et al16 or a single layer of 2-0 Vicryl
if there is not enough laxity to staple the anastomosis. The
anastomosis is then coated with Evicel (OMRIX Biophar-
maceuticals, Somerville, NJ), a fibrin glue product. A lapa-
roscopic J-tube is placed. Two 10-flat Blake closed suction
drains are placed near the anastomosis, and chest tubes
are placed, if needed.
RESULTS
Over the 20-month time period, the surgeon performed 16
esophagectomies (Figure 1). There were 2 MIEs per-
formed in 2006, 6 in 2007, and the remaining 8 performed
in 2008. All patients were men, with an average age of 70
years (range, 54 to 81. Patient comorbidities are listed in
Table 1; the most common comorbidity was hypertension
(found in 62.5% of the patients). Preoperative workup
included an EGD in 11/16 patients, EUS in 13/16 patients,
and PET scan in 9/16 patients. Operative time averaged
198 minutes (range, 147 to 303; median, 166), the average
estimated blood loss was 393mL (range, 100 to 2400;
median, 200), and the length of hospital stay averaged
16.7 days (range, 9 to 30; median, 12; mode, 9). All cases
were performed on an elective basis. The surgeon billed
for 1632 procedures ranging from central line insertions to
complex abdominal operations during the study time pe-
riod. Of these procedures, 483 were laparoscopic. Of the
esophagectomies performed, 14 (87.5%) were resected
successfully in a minimally invasive manner, while 2
(12.5%) were converted to open procedures. One was
converted to an Ivor-Lewis esophagectomy secondary to
tumor extension onto the midportion of the stomach. Thus,
there was an insufficient stomach remnant length to reach
the cervical esophagus. The second conversion was due to a
Figure 1. Esophagectomies per year by a single surgeon.
Table 1.
Patient Comorbidities
Condition Number
of Cases
Percentage
Coronary Artery Disease 3 18.8
Diabetes Mellitus 5 31.3
COPD 2 12.5
Hypertension 10 62.5
Atrial Fibrillation 2 12.5
Asthma 1 6.3
GERD 4 25.0
Hypercholesterolemia 4 25.0
Hiatal Hernia 1 6.3
Ménière’s Disease 1 6.3
Depression 1 6.3
Gout 1 6.3
Benign Prostatic Hypertrophy 3 18.8
Prior Lobectomy 1 6.3
Prostate Cancer 1 6.3
Tobacco use 10 62.5
Alcohol Use 4 25.0
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bilization. This case was converted to a transabdominal
esophagectomy with diaphragmatic split resection. In-
traoperative chest tubes were placed in 10 patients
(62.5%); 6 of these were placed in the right chest, and
4 patients had bilateral chest tubes placed. Eleven pa-
tients received preoperative chemotherapy and radia-
tion treatment.
The 30-day mortality during the study time period was 0.
Estimated 30-day risk-adjusted mortality was calculated at
17.73% with a 95% confidence interval of 0%, 23.36%.17
The postoperative 30-day morbidity included 13 compli-
cations in 7 patients (Table 2). The most common organ
system involved in postoperative complications was the
pulmonary system, with a total of 7 morbidities. Three of
the 16 patients (18.8%) developed pneumonia postoper-
atively, 2 of which were secondary to methicillin-resistant
Staphylococcus aureus. One of the patients who devel-
oped pneumonia subsequently declined into septic shock
with acute respiratory distress syndrome (ARDS) requiring
pressor support. This patient was re-explored on POD 10
and found to have a small segment of ischemic bowel
believed to be secondary to low-flow ischemia and not an
iatrogenic injury from the original surgery. Ultimately, this
patient required a tracheostomy and was discharged to an
extended care facility. Newly diagnosed cardiac issues
including atrial fibrillation (2/16) and asymptomatic sinus
tachycardia (1/16) developed in the postoperative setting.
Of note, 1 patient was diagnosed with a urinary tract
infection postoperatively, and 1 was found to have a
recurrent laryngeal nerve injury.
Pathological analysis confirmed adenocarcinoma in 14
(87.5%) of the surgical specimens. Two (12.5%) of the
patients’ specimens were found to contain only ulcerative
disease, thus confirming complete clinical/pathological
response to the neoadjuvant therapy. The average tumor
diameter was 2.4cm. Barrett’s metaplasia was noted in 3
(18.8%) of the cases. While lymphovascular invasion was
confirmed in 4 (25%) of the specimens, tumor-free mar-
gins were achieved in all 16 (100%) cases. The average
number of retrieved lymph nodes in the surgical specimen
was 11.7 with a mode of 18.
DISCUSSION
Debate continues about the safety of performing esoph-
agectomies in institutions deemed to be low-volume for
the procedure. While there is general consensus to define
low- versus high-volume centers in regard to overall
esophagectomies performed annually, there is a paucity
of information in the current literature to clearly define
these same criteria for those performing an esophagec-
tomy via a minimally invasive approach.3–6,15 However, a
study supported by the American College of Surgeons
Oncology Group (ACOSOG), the E2202 Minimally Inva-
sive Esophagectomy: A Multi-Center Feasibility Study, aims
to help establish a minimally invasive approach to esoph-
ageal resection as the standard of care.16 Thus, with min-
imally invasive techniques increasingly becoming the
norm, we believed it appropriate to determine whether
the volume issue observed in the open esophagectomy
population held true in the minimally invasive population.
In a previous study,15 we reviewed and cited a volume of
10 or more esophagectomies performed per year at a
single institution to define a high-volume center. In keep-
ing with this designation, the present study is, therefore,
compatible with a low-volume institution. In a 20-month
period, the surgeon has performed 16 esophagectomies.
Each of these was initially begun via a minimally invasive
approach, and 14 were successfully completed in this
manner. The conversion rate of 12.5% is considerable;
however, tumor extension onto the stomach requiring a
more involved dissection was necessary to achieve a
proper tension-free anastomosis in one case. Repair of a
membranous trachea iatrogenic injury resulted in the de-
livery of the esophageal segment through the neck inci-
sion in one patient, thus requiring conversion to an open
procedure for proper repair. It is believed that this was the
result of a traction injury caused by the Penrose drain as
the esophageal segment was pulled through while simul-
taneously upward pressure was applied from a long Bab-
cock grasper. It is important to note that the surgeon
referenced here is the only surgeon performing esopha-
geal resections of any type at this institution.
Table 2.
Postoperative Morbidities
Morbidity Number
of Cases
Percentage
Atrial Fibrillation 2 12.5
Small Bowel Resection 1 6.3
Acute Respiratory Distress Syndrome 1 6.3
Pneumonia 3 18.8
Sinus Tachycardia 1 6.3
Tracheostomy 1 6.3
Pleural Effusion 2 12.5
Recurrent Laryngeal Nerve Injury 1 6.3
Urinary Tract Infection 1 6.3
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relatively stagnant irrespective to the approach taken,
open versus minimally invasive. The morbidity at 30-days
postoperatively reported here was 43.75%, comparable to
that of others cited in the current literature. Previous
reports cite a mortality rate ranging from 3% to 20%.3,5,15
The case series presented here demonstrates a 30-day
mortality rate of 0%. The risk-adjusted mortality in this
study is relevant, because it reflects that this population is
typical of those reported elsewhere in the literature. We
also question the comment on the validity of a 30-day
mortality reference when it is a well-known limitation of
any designation of this form, because it is void of com-
ment on patient outcomes after this defined end point.
The percentage of patients who expire after postoperative
day 30 but still within a reasonably short period after
surgery are eliminated from this format of statistical refer-
ence and thus an inherent limitation of this data. Anasto-
motic leaks are one of the most dreaded complications of
this procedure, resulting in an increased mortality rate of
over 35% vs 4.2% in patients without leaks.5 In our case
series, we had no anastomotic leaks. The average length
of stay (LOS) in our report (16.7 days) is longer than those
reported elsewhere; however, we make reference to the
fact that a few patients remained hospitalized for 30 days
thereby skewing the average. A more accurate reflection
of this measure might be the mode LOS, 9 days recorded
for almost half of the patients in this study.
The inherent limitations of this study include the retro-
spective nature of the data collection and the population
size. Due to the lack of uniformity in the collection of
preoperative data, specifically related to preoperative
workup imaging and staging, it is virtually impossible to
draw any justifiable conclusions in regard to the outcomes
in relation to preoperative stage. Despite extensive efforts
to obtain all preoperative imaging studies and reports, we
were unable to collect 100% of these and thus this limits
the applicability of intense discussion regarding this as-
pect of our patient population.
Similar to our previous report, it is our opinion that pre-
operative nutritional optimization is a factor contributing
to our positive results and is of the utmost importance for
the short- and long-term outcomes in this patient popula-
tion. Additionally, each patient is evaluated by pul-
monologist and cardiologist colleagues preoperatively.
This is beneficial in the postoperative time period if any
issue arises; the consultant already has an established
rapport with the patient and his or her specific medical
history. The nursing staffs in both the surgical intensive
care unit and surgical telemetry unit are familiar with the
care of these patients, and this intuitively plays a role in
excellent patient outcomes. While these and other com-
ponents of the perioperative care all contribute to patient
outcomes, it should be mentioned that there was not a
regression analysis undertaken in this study to suggest any
type of causal relationship may exist.15
CONCLUSION
The inherent complexity of this type of operation and the
multitude of other confounding factors present in each
patient make causality statements quite controversial. There-
fore, aside from the small population size, our results would
argue against the volume status of an institution being the
dominant factor in postoperative mortality associated with
MIEs. Rather, we offer surgeon experience and other vari-
ables, such as the meticulous perioperative attention being
paid to nutritional status and both cardiac and pulmonary
optimization, as more prominent factors in mortalities asso-
ciated with MIEs.
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